Sanofi Immunology Investor Event 2022 Dupixent Atopic Dermatitis

Sanofi presented market analysis and patient data for Dupixent across adult and adolescent atopic dermatitis populations in the US, Europe, and Japan. The presentation highlighted prevalence, treatment patterns, and addressable patient populations for the biologic therapy across different disease severity stages.